| Candida Species Identified . | Antifungal Received, No. (%) . | ||
|---|---|---|---|
| . | Total (n = 541) . | E (n = 235) . | TA (n = 306) . |
| C. albicans identified only, No. (%) | 171 (31.6) | 65 (27.7) | 106 (34.6) |
| Single non-albicans identified, No. (%) | 343 (63.4) | 157 (66.8) | 186 (60.8) |
| C. parapsilosis/orthopsilosis/metapsilosis | 156 (28.9) | 49 (20.9) | 107 (35.0) |
| C. tropicalis | 75 (13.9) | 42 (17.9) | 33 (10.8) |
| C. lusitaniae | 36 (6.7) | 20 (8.5) | 16 (5.2) |
| C. glabrata | 35 (6.5) | 28 (11.9) | 7 (2.3) |
| C. guilliermondii | 16 (3.0) | 6 (2.6) | 10 (3.3) |
| C. krusei | 15 (2.8) | 10 (4.3) | 5 (1.6) |
| C. dubliniensis | 6 (1.1) | 2 (0.9) | 4 (1.3) |
| C. pelliculosa | 4 (0.7) | 0 (0) | 4 (1.3) |
| Multiple Candida species identified, No. (%) | 20 (3.7) | 10 (4.3) | 10 (3.3) |
| Single Candida NOS identified, No. (%) | 7 (1.3) | 3 (1.3) | 4 (1.3) |
| Candida Species Identified . | Antifungal Received, No. (%) . | ||
|---|---|---|---|
| . | Total (n = 541) . | E (n = 235) . | TA (n = 306) . |
| C. albicans identified only, No. (%) | 171 (31.6) | 65 (27.7) | 106 (34.6) |
| Single non-albicans identified, No. (%) | 343 (63.4) | 157 (66.8) | 186 (60.8) |
| C. parapsilosis/orthopsilosis/metapsilosis | 156 (28.9) | 49 (20.9) | 107 (35.0) |
| C. tropicalis | 75 (13.9) | 42 (17.9) | 33 (10.8) |
| C. lusitaniae | 36 (6.7) | 20 (8.5) | 16 (5.2) |
| C. glabrata | 35 (6.5) | 28 (11.9) | 7 (2.3) |
| C. guilliermondii | 16 (3.0) | 6 (2.6) | 10 (3.3) |
| C. krusei | 15 (2.8) | 10 (4.3) | 5 (1.6) |
| C. dubliniensis | 6 (1.1) | 2 (0.9) | 4 (1.3) |
| C. pelliculosa | 4 (0.7) | 0 (0) | 4 (1.3) |
| Multiple Candida species identified, No. (%) | 20 (3.7) | 10 (4.3) | 10 (3.3) |
| Single Candida NOS identified, No. (%) | 7 (1.3) | 3 (1.3) | 4 (1.3) |
Abbreviations: NOS, not otherwise specified; E, echinocandins; TA, triazoles or amphotericin B formulations.
| Candida Species Identified . | Antifungal Received, No. (%) . | ||
|---|---|---|---|
| . | Total (n = 541) . | E (n = 235) . | TA (n = 306) . |
| C. albicans identified only, No. (%) | 171 (31.6) | 65 (27.7) | 106 (34.6) |
| Single non-albicans identified, No. (%) | 343 (63.4) | 157 (66.8) | 186 (60.8) |
| C. parapsilosis/orthopsilosis/metapsilosis | 156 (28.9) | 49 (20.9) | 107 (35.0) |
| C. tropicalis | 75 (13.9) | 42 (17.9) | 33 (10.8) |
| C. lusitaniae | 36 (6.7) | 20 (8.5) | 16 (5.2) |
| C. glabrata | 35 (6.5) | 28 (11.9) | 7 (2.3) |
| C. guilliermondii | 16 (3.0) | 6 (2.6) | 10 (3.3) |
| C. krusei | 15 (2.8) | 10 (4.3) | 5 (1.6) |
| C. dubliniensis | 6 (1.1) | 2 (0.9) | 4 (1.3) |
| C. pelliculosa | 4 (0.7) | 0 (0) | 4 (1.3) |
| Multiple Candida species identified, No. (%) | 20 (3.7) | 10 (4.3) | 10 (3.3) |
| Single Candida NOS identified, No. (%) | 7 (1.3) | 3 (1.3) | 4 (1.3) |
| Candida Species Identified . | Antifungal Received, No. (%) . | ||
|---|---|---|---|
| . | Total (n = 541) . | E (n = 235) . | TA (n = 306) . |
| C. albicans identified only, No. (%) | 171 (31.6) | 65 (27.7) | 106 (34.6) |
| Single non-albicans identified, No. (%) | 343 (63.4) | 157 (66.8) | 186 (60.8) |
| C. parapsilosis/orthopsilosis/metapsilosis | 156 (28.9) | 49 (20.9) | 107 (35.0) |
| C. tropicalis | 75 (13.9) | 42 (17.9) | 33 (10.8) |
| C. lusitaniae | 36 (6.7) | 20 (8.5) | 16 (5.2) |
| C. glabrata | 35 (6.5) | 28 (11.9) | 7 (2.3) |
| C. guilliermondii | 16 (3.0) | 6 (2.6) | 10 (3.3) |
| C. krusei | 15 (2.8) | 10 (4.3) | 5 (1.6) |
| C. dubliniensis | 6 (1.1) | 2 (0.9) | 4 (1.3) |
| C. pelliculosa | 4 (0.7) | 0 (0) | 4 (1.3) |
| Multiple Candida species identified, No. (%) | 20 (3.7) | 10 (4.3) | 10 (3.3) |
| Single Candida NOS identified, No. (%) | 7 (1.3) | 3 (1.3) | 4 (1.3) |
Abbreviations: NOS, not otherwise specified; E, echinocandins; TA, triazoles or amphotericin B formulations.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
